Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy-Reference-Cited by-同舟云学术

Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy

Published:2015-11-20 Issue: Volume:5 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Jakobi Annika,Lühr Armin,Stützer Kristin,Bandurska-Luque Anna,Löck Steffen,Krause Mechthild,Baumann Michael,Perrin Rosalind,Richter Christian

Funder

Bundesministerium für Bildung und Forschung

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference42 articles.

1. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Grégoire;Ann Oncol,2010

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective;Marks;Cancer,1982

4. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma;Daly;Head Neck,2007

5. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer;Dawson;Int J Radiat Oncol Biol Phys,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection;Radiotherapy and Oncology;2023-09

2. Comparison of intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer based on radiobiological modelling;Journal of Radiotherapy in Practice;2023

3. Oral Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors: Salivary Gland Dysfunction and Mucosal Diseases;Cancers;2022-02-04

4. Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy;Radiation Oncology;2022-01-03

5. Exposure-response modeling improves selection of radiation and radiosensitizer combinations;Journal of Pharmacokinetics and Pharmacodynamics;2021-10-08